R1	Has_negation Arg1:T2 Arg2:T3	
R2	AND Arg1:T1 Arg2:T2	
*	OR T4 T5
R3	Subsumes Arg1:T1 Arg2:T4	
*	OR T9 T10
R4	Has_negation Arg1:T16 Arg2:T15	
R5	AND Arg1:T14 Arg2:T16	
*	OR T17 T18 T19
R6	AND Arg1:T16 Arg2:T17	
R7	Has_qualifier Arg1:T21 Arg2:T22	
R8	Has_qualifier Arg1:T24 Arg2:T23	
*	OR T21 T24
R9	Has_qualifier Arg1:T25 Arg2:T26	
*	OR T28 T29 T30
R10	Subsumes Arg1:T27 Arg2:T28	
R11	Has_multiplier Arg1:T35 Arg2:T34	
R12	Has_multiplier Arg1:T33 Arg2:T32	
R13	Subsumes Arg1:T33 Arg2:T35	
*	OR T27 T33
T1	Condition 16 29	heart failure
T2	Condition 41 62	diastolic dysfunction
T3	Negation 30 40	other than
T4	Condition 72 98	restrictive cardiomyopathy
T5	Condition 102 129	infiltrative cardiomyopathy
T8	Person 131 136	Women
T9	Condition 145 153	pregnant
T10	Condition 157 164	nursing
T11	Condition 166 181	Liver cirrhosis
T12	Condition 184 208	Primary valvular disease
T13	Condition 210 233	Acute coronary syndrome
T14	Condition 235 247	Causes of PH
T15	Negation 248 258	other than
T16	Condition 267 280	heart failure
T17	Condition 291 316	chronic thromboembolic PH
T18	Condition 318 337	sickle-cell disease
T19	Condition 342 353	sarcoidosis
T21	Condition 362 373	bradycardia
T22	Qualifier 355 361	Severe
T23	Qualifier 377 400	greater than 1st degree
T24	Condition 401 412	heart block
T25	Condition 428 441	heart failure
T26	Qualifier 414 427	Decompensated
T27	Drug 460 489	third generation beta-blocker
T28	Drug 491 500	nebivolol
T29	Drug 502 512	carvedilol
T30	Drug 517 526	labetalol
T32	Multiplier 531 540	high dose
T33	Drug 544 561	any beta-blockers
T34	Multiplier 563 588	greater than 100 mg daily
T35	Drug 592 602	metoprolol
